🔗 Permalink

Inventor profile of:

Peter Kwong

City:

Washington, District of Columbia

Country:

United States

Published Applications:

Last publication date:

2026-06-04

Top Assignees for applications by Peter Kwong

The entities that hold a legal rights for patent applications filed by inventor Kwong Peter:

The United States of America, as represented by the Secretary, Department of Health and Human Services 26 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 15 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 9 Washington, DC United States
INSTITUTE FOR RESEARCH IN BIOMEDICINE 9 Bellinzona, Switzerland
The USA, as represented by the Secretary, Department of Health and Human Services 9 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human 6 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 5 Bethesda, MD United States
UNIVERSITY OF WASHINGTON 3 Seattle, WA United States
International AIDS Vaccine Initiative 2 New York, NY United States
Dana-Farber-Cancer Institute, Inc. 2 Boston, MA United States
The Scripps Research Institute 2 La Jolla, CA United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 2 Washington, DC United States
The Trustees of Columbia University in the City of New York 2 New York, NY United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Services 2 Bethesda, MD United States
TThe United States of America, as represented by the Secretary, Department of Health and Human Servi 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Dept. of Health and Human Service 1 Bethesda, MD United States
The United States of America, as represented by the Sectetary, Department of Health and Human Services 1 Bethesda, MD United States
The United States of America, As Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary,Department of Health and Human Service 1 Bethesda, MD United States
The United States of America, as Represented by the Secretary, Dept of Health & Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serices 1 Bethesda, MD United States
The General Hospital Corporation 1 Boston, MA United States
The United States of America, as represented by the Secretary, Department of Health and Human Ser. 1 Bethesda, MD United States
The United States of AMerica, as represented by the Secretary, Department of Health and Human Serc 1 Bethesda, MD United States
NATIONAL INSTITUTES OF HEALTH 1 Bethesda, MD United States
Board of Regents, The University of Texas System 1 Austin, TX United States
Dana-Faber Cancer Institute, Inc. 1 Boston, MA United States
The United States of America, as represented by the Secretary, Department of Health and Human Servi 1 Bethesda, MD United States
The University of North Carolina at Chapel Hill 1 Chapel Hill, NC United States
The United States of America, as repsented By the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
The U.S.A., as represented by the Secretary, Department of Health and Human Service 1 Bethesda, MD United States
The United State of America, as represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretay, Deparment of Health and human Servi 1 Bethesda, MD United States

Recent patent applications by Kwong Peter

Peter Kwong from Washington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-04

US20260152546A1

Chemistry; metallurgy

NOVEL ANTIBODIES FOR HIV AND METHODS OF MAKING AND USING SAME

#2 | 2026-05-28

US20260144860A1

Human necessities

HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE

#3 | 2026-01-22

US20260022145A1

Chemistry; metallurgy

PREFUSION PIV F IMMUNOGENS AND THEIR USE

#4 | 2025-12-25

US20250388627A1

Chemistry; metallurgy

PREFUSION RSV F PROTEINS AND THEIR USE

#5 | 2025-12-25

US20250387464A1

Human necessities

RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE

#6 | 2025-07-03

US20250215068A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

#7 | 2025-06-19

US20250197482A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE

#8 | 2025-06-19

US20250197455A1

Chemistry; metallurgy

BASE-COVERED HIV-1 ENVELOPE ECTODOMAINS AND THEIR USE

#9 | 2025-06-05

US20250179154A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

#10 | 2025-01-09

US20250011406A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

#11 | 2024-09-19

US20240309053A1

Chemistry; metallurgy

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

#12 | 2024-08-29

US20240287144A1

Chemistry; metallurgy

SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES

#13 | 2024-07-11

US20240228549A1

Chemistry; metallurgy

PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE

#14 | 2024-06-27

US20240209032A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#15 | 2024-03-28

US20240101609A1

Chemistry; metallurgy

PREFUSION PIV F IMMUNOGENS AND THEIR USE

#16 | 2024-01-25

US20240024458A1

Human necessities

Recombinant metapneumovirus f proteins and their use

#17 | 2023-11-30

US20230381293A1

Human necessities

STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS

#18 | 2023-10-26

US20230338507A1

Human necessities

HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE

#19 | 2023-09-14

US20230287055A1

Chemistry; metallurgy

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

#20 | 2023-07-20

US20230227512A1

Chemistry; metallurgy

Recombinant HIV-1 envelope proteins and their use

#21 | 2023-06-08

US20230174587A1

Chemistry; metallurgy

RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE

#22 | 2023-03-02

US20230060304A1

Chemistry; metallurgy

Neutralizing antibodies to GP120 and their use

#23 | 2022-03-31

US20220098286A1

Chemistry; metallurgy

10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use

#24 | 2022-03-03

US20220064222A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#25 | 2022-01-27

US20220024987A1

Chemistry; metallurgy

Prefusion PIV F immunogens and their use

#26 | 2021-11-18

US20210353740A1

Human necessities

HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use

#27 | 2021-10-21

US20210324053A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

#28 | 2021-09-16

US20210283240A1

Human necessities

Recombinant metapneumovirus F proteins and their use

#29 | 2021-07-01

US20210198324A1

Chemistry; metallurgy

Self-assembling insect ferritin nanoparticles

#30 | 2021-06-24

US20210188921A1

Chemistry; metallurgy

Recombinant HIV-1 envelope proteins and their use

#31 | 2021-03-18

US20210079070A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 Env and their use

#32 | 2020-09-03

US20200277338A1

Chemistry; metallurgy

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

#33 | 2020-07-23

US20200231658A1

Chemistry; metallurgy

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

#34 | 2020-07-23

US20200230229A1

Human necessities

HIV-1 Env fusion peptide immunogens and their use

#35 | 2020-02-13

US20200048311A1

Chemistry; metallurgy

Prefusion PIV F immunogens and their use

#36 | 2020-01-09

US20200009243A1

Human necessities

Recombinant metapneumovirus F proteins and their use

#37 | 2019-12-26

US20190389915A1

Chemistry; metallurgy

Recombinant HIV-1 envelope proteins and their use

#38 | 2019-10-31

US20190330279A1

Chemistry; metallurgy

Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

#39 | 2019-04-18

US20190112340A1

Chemistry; metallurgy

Substitutions-modified prefusion RSV F proteins and their use

#40 | 2019-03-14

US20190077849A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 GP41 and their use

#41 | 2018-11-01

US20180312544A1

Chemistry; metallurgy

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

#42 | 2018-10-18

US20180298083A1

Chemistry; metallurgy

Neutralizing antibodies to gp120 and their use

#43 | 2018-01-11

US20180008697A1

Human necessities

Recombinant metapneumovirus F proteins and their use

#44 | 2018-01-04

US20180002406A1

Chemistry; metallurgy

Neutralizing GP41 antibodies and their use

#45 | 2017-12-28

US20170369558A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 and their use

#46 | 2017-10-19

US20170298101A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#47 | 2017-08-17

US20170233441A1

Chemistry; metallurgy

Recombinant HIV-1 envelope proteins and their use

#48 | 2016-11-17

US20160333076A1

Chemistry; metallurgy

Neutralizing GP41 antibodies and their use

#49 | 2016-10-06

US20160289305A1

Chemistry; metallurgy

HIV-1 broadly neutralizing antibodies

#50 | 2016-01-14

US20160009789A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 and their use

#51 | 2014-11-27

US20140348865A1

Chemistry; metallurgy

IMMUNOGENS BASED ON AN HIV-1 V1V2 SITE-OF-VULNERABILITY

#52 | 2014-11-27

US20140348785A1

Chemistry; metallurgy

Neutralizing GP41 antibodies and their use

#53 | 2014-09-18

US20140271699A1

Chemistry; metallurgy

Prefusion RSV F proteins and their use

#54 | 2013-09-26

US20130251726A1

Chemistry; metallurgy

HIV-1 broadly neutralizing antibodies

#55 | 2012-12-27

US20120328641A1

Chemistry; metallurgy

Conformationally stabilized HIV envelope immunogens

#56 | 2012-11-08

US20120282264A1

Chemistry; metallurgy

Neutralizing antibodies to HIV-1 and their use

#57 | 2012-02-09

US20120034255A1

Chemistry; metallurgy

Conformationally stabilized HIV envelope immunogens

#58 | 2009-07-30

US20090191235A1

Chemistry; metallurgy

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

InventorID:

455159 ⎘